Future Prospects?17 Jan 2022 16:21
This appears to be, from where I am sat at least, very under-loved and overly sold. MCAP currently standing at £10M net cash at £5M. Recent loss of contract in RNS expected to hit -£300k in revenue, which is around 10% of gross revenue, but not sure how that warrants a 40% drop in the share price, compounded against the yearly drop it has already suffered given some of the high profile clients it has on its book. I can likely see dividends possibly being scrapped, and in a way I’d rather them do that, pay down some debt and better stabilise the foundations of the company whilst riding through the pandemic. However, I am not sure if that is likely to happen given such a high percentage of individual investors in the company.
A very difficult company to analyse, but one of the better ones within the Microcap segment. I note that it was rated a recovery buy from ST at IC on 06/09/21 when the price was 135p - a further 44% decline to the share price on -£300,000 revenue doesn’t add up in my eyes.
I would welcome other peoples views here as this is an incredibly niche industry and market to both value and penetrate…